Position in JAZZ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$946,048
-$536,702 QoQ
Shares Held
3,926
-65.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#327
of 629 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 54%
Shared 0%
None 46%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Allianz SE holds $20,490,193 across 10 Biotechnology names. JAZZ ranks #4 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,921 | $11,882,277 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
73,400 | $4,199,948 | |
| 3 | ASND |
Ascendis Pharma A/S
|
5,077 | $1,354,137 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
3,926 | $946,048 | |
| 5 | FTRE |
Fortrea Holdings Inc.
|
48,000 | $835,200 | |
| 6 | BNTX |
BioNTech SE
|
5,380 | $500,609 | |
| 7 | GNTA |
Genenta Science S.p.A.
|
234,050 | $430,652 | |
| 8 | MRNA |
Moderna, Inc.
|
4,326 | $302,949 |
All Filings in JAZZ
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $946,048 | 3,926 | Shares | Defined | 2026-08-10 | |
| 2025-09-30 | $1,482,750 | 11,250 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,190,666 | 11,220 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $29,299 | 236 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $29,063 | 236 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $61,275 | 550 | Shares | Defined | 2025-05-12 | |
| 2024-06-30 | $99,258 | 930 | Shares | Defined | 2025-05-12 | |
| 2024-03-31 | $111,990 | 930 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||